(Press-News.org) PITTSBURGH, June 28, 2013 -- A single systemic dose of special immune cells prevented rejection for almost four months in a preclinical animal model of kidney transplantation, according to experts at the University of Pittsburgh School of Medicine. Their findings, now available in the online version of the American Journal of Transplantation, could lay the foundation for eventual human trials of the technique.
Organ transplantation has saved many lives, but at the cost of sometimes lifelong requirements for powerful immunosuppressive medication that can have serious side effects, said senior investigator Angus Thomson, Ph.D., D.Sc., distinguished professor of surgery and of immunology, Pitt School of Medicine. Scientists have long sought ways to encourage the organ recipient's immune system to accept or tolerate the donor organ to reduce the need for drugs to stave off rejection.
"This study shows it is possible to prepare the patient's immune system for a donor kidney by administering specially treated immune cells from the donor in advance of the transplant surgery," Dr. Thomson said. "This could be very helpful in the context of planned kidney donations from living relatives, and could one day be adapted to transplantation from deceased donors."
For the project, the research team generated immune cells called dendritic cells (DCs) from the blood of rhesus macaques that would later provide a kidney to recipient monkeys. Dendritic cells are known to be key regulators of the immune system by showing antigens to T-cells to either activate them against the foreign protein or to suppress the T-cell response. The researchers treated the donor DCs in the lab to prevent them from fully maturing and having the capacity to trigger an immune reaction against foreign proteins.
One week before having a kidney transplant, recipient monkeys received a single infusion of treated DCs obtained from their respective donor animals. Another group of monkeys was transplanted without receiving the cells, but both groups were given the same regimen of immunosuppression drugs, a modified protocol for experimental purposes that eventually results in donor organ rejection. The researchers found that the donor kidney was rejected in about 40 days among animals that got only the drugs, but survived for about 113 days in the group that had a prior infusion of treated DCs.
The modified donor DCs sent signals to the recipient immune system to stay quiet and not launch an attack against the donor organ, explained lead author Mohamed Ezzelerab, M.D., research assistant professor, Department of Surgery, Pitt School of Medicine.
"The results indicate that we achieved immune system regulation without side effects of the DCs, but better yet, the monkeys were healthier from a clinical perspective," he said. "They maintained a better weight, had less protein in the urine and fewer signs of kidney damage than the other group. Ultimately, all these factors played a role in prolonging organ survival in the group that received DC therapy."
###
Co-authors of the paper include other researchers from the Thomas E. Starzl Transplantation Institute, and the departments of Surgery, Immunology, Medicine and Pathology, Pitt School of Medicine. The project was funded by National Institutes of Health grant AI051698.
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu.
http://www.upmc.com/media
Dendritic cell therapy improves kidney transplant survival, Pitt team says
2013-06-28
ELSE PRESS RELEASES FROM THIS DATE:
Pluripotent stem cell-derived neurons may be a viable Parkinson's disease treatment
2013-06-28
Putnam Valley, NY. (Jun. 28 2013) – A team of researchers from Rush University, Yale University, the University of Colorado and the St. Kitts Biomedical Research Foundation transplanted human embryonic stem cells into primate laboratory animals modeled with Parkinson's disease and found "robust survival" of the cells after six weeks and indications that the cells were "well integrated" into the host animals. The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/pre-prints/ct1000wakeman. ...
SCI patients treated with own olfactory ensheathing cells realize neurologic improvement
2013-06-28
Putnam Valley, NY. (June 28 2013) – A team of researchers in Poland who treated three of six paraplegics with spinal cord injury using transplanted olfactory ensheathing cells found that the three treated patients showed neurological improvement and no adverse effects while the three control patients who did not receive transplants saw no improvement.
The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/pre-prints/ct0799tabakow.
"Most accepted treatments ...
Is it alive or dead?
2013-06-28
WASHINGTON D.C., June 27, 2013 -- To the ancients, probing the philosophical question of how to distinguish the living from the dead centered on the "mystery of the vital heat." To modern microbiology, this question was always less mysterious than it was annoying -- researchers have known that biological processes should produce thermal signatures, even within single cells, but nobody ever knew how to measure them.
Now, a group of mechanical engineers from Pohang University of Science and Technology in Korea have discovered a way to measure the "thermal conductivity" ...
Type 2 diabetes patients transplanted with own bone marrow stem cells reduces insulin use
2013-06-28
Putnam Valley, NY. (June 28 2013) –A study carried out in India examining the safety and efficacy of self-donated (autologous), transplanted bone marrow stem cells in patients with type 2 diabetes (TD2M), has found that patients receiving the transplants, when compared to a control group of TD2M patients who did not receive transplantation, required less insulin post-transplantation.
The study appears as an early e-publication for the journal Cell Transplantation, and is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/pre-prints/ct0920bhansali.
"There ...
Scientists view 'protein origami' to help understand, prevent certain diseases
2013-06-28
COLLEGE STATION -- Scientists using sophisticated imaging techniques have observed a molecular protein folding process that may help medical researchers understand and treat diseases such as Alzheimer's, Lou Gehrig's and cancer.
The study, reported this month in the journal Cell, verifies a process that scientists knew existed but with a mechanism they had never been able to observe, according to Dr. Hays Rye, Texas A&M AgriLife Research biochemist.
"This is a step in the direction of understanding how to modulate systems to prevent diseases ...
Rice U. releases findings from national Portraits of American Life Study
2013-06-28
Americans are more respectful now than ever before when it comes to the religious traditions of their peers, according to findings from the longitudinal Rice University Portraits of American Life Study (PALS). Other findings: Americans are more divided on the legal definition of marriage, favor restrictions on abortion, support pathways to citizenship for undocumented immigrants and are less politically engaged (with the exception of African-Americans).
PALS is a six-year national study tracking religion, morality, politics and other social issues in the U.S. The study ...
Specialized treatment helps cholesterol patients who suffer side effects from statins
2013-06-28
MAYWOOD, Il. - Up to 15 percent of patients who take cholesterol-lowering statin medications experience muscle pain or other side effects, and many patients simply stop taking the drugs.
But a Loyola University Medical Center study has found that "statin-intolerant" patients still can significantly reduce their cholesterol by going to a lipid clinic staffed with physicians specially trained in treating cholesterol problems.
Among 22 statin-intolerant patients referred to Loyola's Lipid Clinic, total cholesterol dropped from 257 mg/dl to 198 mg/dl. LDL ("bad") cholesterol ...
Study links cardiac hormone-related inflammatory pathway with tumor growth
2013-06-28
Tampa, FL (June 28, 2013) -- A cardiac hormone signaling receptor abundantly expressed both in inflamed tissues and cancers appears to recruit stem cells that form the blood vessels needed to feed tumor growth, reports a new study by scientists at the University of South Florida Nanomedicine Research Center.
The research may lead to the development of new drugs or delivery systems to treat cancer by blocking this receptor, known as natriuretic peptide receptor A (NPRA).
The findings appeared online recently in the journal Stem Cells.
"Our results show that NRPA signaling ...
Major changes needed for coral reef survival
2013-06-28
Washington, D.C.—To prevent coral reefs around the world from dying off, deep cuts in carbon dioxide emissions are required, says a new study from Carnegie's Katharine Ricke and Ken Caldeira. They find that all existing coral reefs will be engulfed in inhospitable ocean chemistry conditions by the end of the century if civilization continues along its current emissions trajectory. Their work will be published July 3 by Environmental Research Letters.
Coral reefs are havens for marine biodiversity and underpin the economies of many coastal communities. But they are very ...
Interplay of ecology, infectious disease, wildlife and human health featured at annual conference
2013-06-28
West Nile virus, Lyme disease and hantavirus. All are infectious diseases spreading in animals and in people. Is human interaction with the environment somehow responsible for the increase in these diseases?
The ecology and evolution of infectious diseases will be highlighted at two symposia at the Ecological Society of America's annual meeting, held from Aug. 5-9 in Minneapolis, Minn.
One symposium will address human influences on viral and bacterial diseases through alteration of landscapes and ecological processes.
Another will focus on the emerging field of eco-epidemiology, ...